-
1
Low dose naltrexone (LDN) was prescribed to 10 patients with fibromyalgia, resulting in substantial pain relief for 8 patients.
-
2
Patients reported additional health benefits from LDN, including improved quality of life, reduced pain flares, and better sleep.
-
3
Two patients discontinued LDN due to side effects, specifically increased pain, while LDN was generally well tolerated.
-
4
The study highlights the potential of LDN as an effective off-label treatment for fibromyalgia, despite mixed findings in larger trials.
-
5
The research emphasizes the importance of slow dose titration of LDN and its proposed mechanism involving hormesis at opioid receptors.